Global Embolization Particle market will reach 3100 million US$ by the end of 2025

Global Embolization Particle market will reach 3100 million US$ by the end of 2025 Custom Research｜Research Report｜Management Consulting｜Seminar｜Database

CONTACT Beijing Hengzhou Bozhi International Information Consulting Web: www.qyresearch.com TEL:+86-13660489419, Office:+86-2022093278 Media: press@qyresearch.com Marketing: sales@qyresearch.com Facebook: @QYResearchOfficial Twitter: @QYResearch_ Wechat Official Account: QYResearch, Weibo: 恒州博智

QYResearch

•

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

•

USA has the largest global export quantity and manufacturers in Embolization Particle market, while the Europe is the second sales volume market for Embolization Particle in 2016.

QYResearch

In the industry, Sirtex Medical profits most in 2016 and recent years, while Merit Medical and BTG Medical ranked 2 and 3.The market share of them is 23.11%, 17.44% and 14.53% in 2016.The gap of market share is keep on enlarged due to different strategy.

Nowadays, there are four mainly types of Embolization Particle, including Microspheres, Particles, DEBs and Radio-Embolic Microspheres. And Microspheres is the main type for Embolization Particle, and the Microspheres reached a sales value of approximately 347.54 M USD in 2016, with 34.55% of global sales volume.

QYResearch

•

The global Embolization Particle market is valued at 1170 million US$ in 2017 and will reach 3100 million US$ by the end of 2025, growing at a CAGR of 13.0% during 2018-2025.

Click to view the full report: https://www.qyresearch.com/index/detail/600178/globalembolization-particle-market